Other Assets, Noncurrent in USD of Horizon Therapeutics Public Ltd Co from Q4 2010 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Horizon Therapeutics Public Ltd Co quarterly Other Assets, Noncurrent history and change rate from Q4 2010 to Q2 2023.
  • Horizon Therapeutics Public Ltd Co Other Assets, Noncurrent for the quarter ending 30 Jun 2023 was $263M, a 63.8% increase year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Change (%)

Horizon Therapeutics Public Ltd Co Quarterly Other Assets, Noncurrent (USD)

Period Value YoY Chg Change % Date Report Filed
Q2 2023 $263M +$102M +63.8% 30 Jun 2023 10-Q 08 Aug 2023
Q1 2023 $188M +$25.4M +15.6% 31 Mar 2023 10-Q 03 May 2023
Q4 2022 $204M +$63.4M +45% 31 Dec 2022 10-Q 08 Aug 2023
Q3 2022 $204M +$77.7M +61.7% 30 Sep 2022 10-Q 02 Nov 2022
Q2 2022 $161M +$28M +21.1% 30 Jun 2022 10-Q 03 Aug 2022
Q1 2022 $162M +$105M +184% 31 Mar 2022 10-Q 04 May 2022
Q4 2021 $141M +$85M +153% 31 Dec 2021 10-K 01 Mar 2023
Q3 2021 $126M +$75.8M +151% 30 Sep 2021 10-Q 03 Nov 2021
Q2 2021 $133M +$91.7M +224% 30 Jun 2021 10-Q 04 Aug 2021
Q1 2021 $57.2M +$14.2M +33.2% 31 Mar 2021 10-Q 05 May 2021
Q4 2020 $55.7M +$7.39M +15.3% 31 Dec 2020 10-K 01 Mar 2022
Q3 2020 $50.1M +$7.93M +18.8% 30 Sep 2020 10-Q 02 Nov 2020
Q2 2020 $40.9M -$2.88M -6.58% 30 Jun 2020 10-Q 05 Aug 2020
Q1 2020 $42.9M -$1.83M -4.09% 31 Mar 2020 10-Q 06 May 2020
Q4 2019 $48.3M +$39.4M +439% 31 Dec 2019 10-K 24 Feb 2021
Q3 2019 $42.2M +$14.7M +53.6% 30 Sep 2019 10-Q 06 Nov 2019
Q2 2019 $43.8M +$14.5M +49.8% 30 Jun 2019 10-Q 07 Aug 2019
Q1 2019 $44.8M +$18M +67.2% 31 Mar 2019 10-Q 08 May 2019
Q4 2018 $8.96M -$27.1M -75.2% 31 Dec 2018 10-K 26 Feb 2020
Q3 2018 $27.5M -$8.77M -24.2% 30 Sep 2018 10-Q 07 Nov 2018
Q2 2018 $29.2M -$621K -2.08% 30 Jun 2018 10-Q 08 Aug 2018
Q1 2018 $26.8M +$23.9M +842% 31 Mar 2018 10-Q 09 May 2018
Q4 2017 $36.1M +$33.7M +1424% 31 Dec 2017 10-K 27 Feb 2019
Q3 2017 $36.2M +$30M +484% 30 Sep 2017 10-Q 06 Nov 2017
Q2 2017 $29.8M +$23.7M +385% 30 Jun 2017 10-Q 07 Aug 2017
Q1 2017 $2.84M +$2.24M +374% 31 Mar 2017 10-Q 08 May 2017
Q4 2016 $2.37M +$2.15M +967% 31 Dec 2016 10-K 28 Feb 2018
Q3 2016 $6.2M -$3.31M -34.8% 30 Sep 2016 10-Q 07 Nov 2016
Q2 2016 $6.16M -$3.46M -36% 30 Jun 2016 10-Q 08 Aug 2016
Q1 2016 $600K -$9.99M -94.3% 31 Mar 2016 10-Q 09 May 2016
Q4 2015 $222K -$11.3M -98.1% 31 Dec 2015 10-K 27 Feb 2017
Q3 2015 $9.51M -$6.02M -38.8% 30 Sep 2015 10-Q 06 Nov 2015
Q2 2015 $9.62M +$3.45M +56.1% 30 Jun 2015 10-Q 07 Aug 2015
Q1 2015 $10.6M +$4.09M +63% 31 Mar 2015 10-Q 08 May 2015
Q4 2014 $11.6M +$4.61M +66.2% 31 Dec 2014 10-K 29 Feb 2016
Q3 2014 $15.5M +$12.1M +351% 30 Sep 2014 10-Q 06 Nov 2014
Q2 2014 $6.16M +$2.32M +60.5% 30 Jun 2014 10-Q 07 Aug 2014
Q1 2014 $6.5M +$2.32M +55.7% 31 Mar 2014 10-Q 09 May 2014
Q4 2013 $6.96M +$2.51M +56.4% 31 Dec 2013 10-K/A 02 Mar 2015
Q3 2013 $3.45M -$524K -13.2% 30 Sep 2013 10-Q 08 Nov 2013
Q2 2013 $3.84M -$240K -5.88% 30 Jun 2013 10-Q 09 Aug 2013
Q1 2013 $4.17M -$89K -2.09% 31 Mar 2013 10-Q 10 May 2013
Q4 2012 $4.45M +$3.9M +713% 31 Dec 2012 10-K 13 Mar 2014
Q3 2012 $3.97M +$3.42M +626% 30 Sep 2012 10-Q 13 Nov 2012
Q2 2012 $4.08M +$133K +3.37% 30 Jun 2012 10-Q 10 Aug 2012
Q1 2012 $4.26M 31 Mar 2012 10-Q 10 May 2012
Q4 2011 $547K -$2.93M -84.3% 31 Dec 2011 10-K 18 Mar 2013
Q3 2011 $547K 30 Sep 2011 10-Q 14 Nov 2011
Q2 2011 $3.95M 30 Jun 2011 10-Q 02 Sep 2011
Q4 2010 $3.47M 31 Dec 2010 10-K 23 Mar 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.